Motley Fool Premium
  1. Stocks
    2. /
  2. Knight Therapeutics (TSX: GUD)
    3. /

TSX:GUD (Knight Therapeutics)

About GUD

Knight Therapeutics, Inc. engages in the business of acquiring, in licensing, out-licensing, marketing, and commercializing pharmaceuticals products. The firm also focuses on building a portfolio of innovative products through in-licensing or acquiring product rights. The company was founded by Jonathan Ross Goodman on November 1, 2013 and is headquartered in Montréal, Canada.
Financial Market Data copyright © 2026 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Knight Therapeutics (TSX: GUD) Latest News

    lab worker inspects test tubes
    Dividend Stocks

    3 Biotech Stocks to Buy Before the Down Market Is Over

    | Christopher Liew, CFA

    Biotech stocks are high-risk, high-reward investments, although three names are buying opportunities in the current down market.

    Read more »

    Workers use a microscope to do medical research in a modern laboratory.
    Investing

    This Biotech Stock Could Offer Big Growth – Even During a Recession

    | Chris MacDonald

    Here's why Knight Therapeutics (TSX:GUD) is one biotech stock that's worth a buy, or at least a look, in this…

    Read more »

    Stocks for Beginners

    2 Health Care Stocks Could Return at Least 50% in 1 Year

    | Christopher Liew, CFA

    The health care sector continues to underperform, although two stocks could deliver superior returns in one year.

    Read more »

    Investing

    Can the Healthcare Sector Rebound in 2022?

    | Adam Othman

    Despite the overall downfall of the healthcare sector (weighed down by marijuana companies), there are stocks that might display strong…

    Read more »

    Investing

    Strong Buy Ratings: 2 Healthcare Stocks With More Than 40% Upside

    | Christopher Liew, CFA

    The healthcare sector has two constituents that could deliver more than 40% in capital gains. Invest in WELL Health Technologies…

    Read more »

    Coronavirus

    Forget Trillium Therapeutics Stock (TSX:TRIL): Buy These Pharma Stocks Instead!

    | Amy Legate-Wolfe

    Motley Fool investors who want in on a pharma rebound should definitely look into these stocks over Trillium Therapeutics stock…

    Read more »

    Investing

    TFSA Investors: 1 Low-Risk Value Stock With Significant Upside

    | Nikhil Kumar

    Knight Therapeutics Inc. (TSX:GUD) is focused on building a portfolio of innovative products through in-licensing or acquiring product rights.

    Read more »

    Coronavirus

    Got $3,000? 3 Dirt-Cheap TSX Stocks to Buy Today

    | Ambrose O'Callaghan

    Canadians who are looking to splurge in September should look to oversold TSX stocks like Knight Therapeutics Inc. (TSX:GUD).

    Read more »

    Dividend Stocks

    TFSA: 3 Super Stocks That Can Make You Rich

    | Ambrose O'Callaghan

    Top healthcare stocks like Savaria Corporation (TSX:SIS) have huge potential, which is why TFSA investors should target them today.

    Read more »

    Investing

    Top TSX Stocks Under $10

    | Ambrose O'Callaghan

    Markets have been somewhat volatile to close out this month, so investors should target TSX stocks that are on the…

    Read more »

    Coronavirus

    2 TSX Pharma Stocks That Can Make You a TFSA Millionaire

    | Aditya Raghunath

    Here's why you can buy shares of Viemed Healthcare and Knight Therapeutics right now!

    Read more »

    Investing

    TFSA: 3 Healthcare Stocks That Can Make You Filthy Rich

    | Ambrose O'Callaghan

    TFSA investors should be on the hunt for the kind of growth offered by healthcare stocks like Knight Therapeutics Inc.…

    Read more »